Had a couple of days away from posting as it was getting a bit pointless with some of the posts - That seems to be sorted now ;)
Just a hypothetical question for any holders to ponder :
Surges - We mentioned Quanterix Corporation in earlier posts and their new test with 1000 fold increases in sensitivity with their new AccuPSA test. They also presented at AACC in Atlanta this week.
My questions are to anyone -
* What if mixngo is in Quanterixs new test?
* Novartis signed an "Evaluation Agreement" to assess this technology of Quanterix's earlier this year
* From what I can see Novartis has annual sales of about $60 billion dollars and are listed on NYSE with a MCAP of $139 BILLION
Surges would like your thoughts thanks
ADO Price at posting:
7.7¢ Sentiment: LT Buy Disclosure: Held
